Fig. 1From: NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxelThe upregulation of NFATc2 in dorsal horn neurons was involved in the mechanical allodynia induced by paclitaxel. a Treatment with paclitaxel decreased the hind paw withdraw threshold in rats (**P < 0.01 vs the vehicle group/day 10, n = 12 per group). b Representative blots and histogram showed the upregulation of NFATc2 following paclitaxel application on both total and nucleus level (**P < 0.01 vs the vehicle group/day 10, n = 4 per group). c The immunofluorescence signal of NFATc2 (red) was colocalized with NeuN (neurons marker, green), but not Iba-1 (microglia marker, green) or GFAP (astrocyte marker, green) or Sox10 (oligodendrocyte maker, green) in both vehicle group and paclitaxel group. Left scale bar, 100 μm; right scale bar, 20 μm (n = 3 per group). d, e Intrathecal injection of the NFATc2 siRNA significantly decreased the expression of NFATc2 mRNA and protein (**P < 0.01 vs the scramble group, n = 5 or 4 per group). f, g Deletion of NFATc2 in dorsal horn significantly attenuated the mechanical allodynia and thermal hyperalgesia induced by paclitaxel in the rats (**P < 0.01 vs the vehicle group, ##P < 0.01 vs the paclitaxel group, n = 12 per group)Back to article page